Literature DB >> 17570247

Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.

Yan Zhang1, Nilesh W Gaikwad, Kevin Olson, Muhammad Zahid, Ercole L Cavalieri, Eleanor G Rogan.   

Abstract

Accumulating evidence suggests that specific metabolites of estrogens, namely, catechol estrogen quinones, react with DNA to form adducts and generate apurinic sites, which can lead to the mutations that induce breast cancer. Oxidation of estradiol (E(2)) produces 2 catechol estrogens, 4-hydroxyestradiol (4-OHE(2)) and 2-OHE(2) among the major metabolites. These, in turn, are oxidized to the quinones, E(2)-3,4-quinone (E(2)-3,4-Q) and E(2)-2,3-Q, which can react with DNA. Oxidation of E(2) to 2-OHE(2) is mainly catalyzed by cytochrome P450 (CYP) 1A1, and CYP3A4, whereas oxidation of E(2) to 4-OHE(2) in extrahepatic tissues is mainly catalyzed by CYP1B1 as well as some CYP3As. The potential involvement of CYP isoforms in the further oxidation of catechols to semiquinones and quinones has, however, not been investigated in detail. In this project, to identify the potential function of various CYPs in oxidizing catechol estrogens to quinones, we used different recombinant human CYP isoforms, namely, CYP1A1, CYP1B1, and CYP3A4, with the scope of oxidizing the catechol estrogens 2-OHE(2) and 4-OHE(2) to their respective estrogen quinones, which then reacted with DNA. The depurinating adducts 2-OHE(2)-6-N3Ade, 4-OHE(2)-1-N3Ade, and 4-OHE(2)-1-N7Gua were observed in the respective reaction systems by ultraperformance liquid chromatography/tandem mass spectrometry. Furthermore, more than 100-fold higher levels of estrogen-glutathione (GSH) conjugates were detected in the reactions. Glutathione conjugates were observed, in much smaller amounts, when control microsomes were used. Depurinating adducts, as well as GSH conjugates, were obtained when E(2)-3,4-Q was incubated with CYP1B1 or control microsomes in a 30-minute reaction, further demonstrating that GSH is present in these recombinant enzyme preparations. These experiments demonstrated that CYP1A1, CYP1B1, and CYP3A4 are able to oxidize catechol estrogens to their respective quinones, which can further react with GSH, protein, and DNA, the last resulting in depurinating adducts that can lead to mutagenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570247     DOI: 10.1016/j.metabol.2007.03.001

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  20 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

2.  Selective estrogen receptor modulator (SERM) lasofoxifene forms reactive quinones similar to estradiol.

Authors:  Bradley T Michalsen; Teshome B Gherezghiher; Jaewoo Choi; R Esala P Chandrasena; Zhihui Qin; Gregory R J Thatcher; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2012-06-14       Impact factor: 3.739

3.  Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT.

Authors:  Cher M Dallal; Jeffrey A Tice; Diana S M Buist; Douglas C Bauer; James V Lacey; Jane A Cauley; Trisha F Hue; Andrea Lacroix; Roni T Falk; Ruth M Pfeiffer; Barbara J Fuhrman; Timothy D Veenstra; Xia Xu; Louise A Brinton
Journal:  Carcinogenesis       Date:  2013-11-08       Impact factor: 4.944

4.  Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.

Authors:  Inik Chang; Shinichiro Fukuhara; Darryn K Wong; Ankurpreet Gill; Yozo Mitsui; Shahana Majid; Sharanjot Saini; Soichiro Yamamura; Takeshi Chiyomaru; Hiroshi Hirata; Koji Ueno; Sumit Arora; Varahram Shahryari; Guoren Deng; Z Laura Tabatabai; Kirsten L Greene; Dong Min Shin; Hideki Enokida; Hiroaki Shiina; Norio Nonomura; Rajvir Dahiya; Yuichiro Tanaka
Journal:  Tumour Biol       Date:  2014-07-17

5.  Functional differences in the cytochrome P450 1 family enzymes from zebrafish (Danio rerio) using heterologously expressed proteins.

Authors:  Marcus L Scornaienchi; Cammi Thornton; Kristine L Willett; Joanna Y Wilson
Journal:  Arch Biochem Biophys       Date:  2010-06-18       Impact factor: 4.013

6.  Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.

Authors:  Brenda Diergaarde; John D Potter; Eldon R Jupe; Sharmila Manjeshwar; Craig D Shimasaki; Thomas W Pugh; Daniele C Defreese; Bobby A Gramling; Ilonka Evans; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

Review 7.  Mass spectrometry techniques in the survey of steroid metabolites as potential disease biomarkers: a review.

Authors:  Maria João Gouveia; Paul J Brindley; Lúcio Lara Santos; José Manuel Correia da Costa; Paula Gomes; Nuno Vale
Journal:  Metabolism       Date:  2013-05-07       Impact factor: 8.694

8.  Association of genetic variants of xenobiotic and estrogen metabolism pathway (CYP1A1 and CYP1B1) with gallbladder cancer susceptibility.

Authors:  Kiran Lata Sharma; Akash Agarwal; Sanjeev Misra; Ashok Kumar; Vijay Kumar; Balraj Mittal
Journal:  Tumour Biol       Date:  2014-02-18

9.  Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.

Authors:  Jiaqi Fu; Amy M Weise; Josie L Falany; Charles N Falany; Bryan J Thibodeau; Fred R Miller; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Breast Cancer Res Treat       Date:  2009-03-24       Impact factor: 4.872

10.  Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B ∼ FIT Cohort.

Authors:  Cher M Dallal; James V Lacey; Ruth M Pfeiffer; Douglas C Bauer; Roni T Falk; Diana S M Buist; Jane A Cauley; Trisha F Hue; Andrea Z LaCroix; Jeffrey A Tice; Timothy D Veenstra; Xia Xu; Louise A Brinton
Journal:  Horm Cancer       Date:  2016-01-04       Impact factor: 3.869

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.